Related Experiment Videos
Does ozone alleviate AIDS diarrhea?
M T Carpendale1, J Freeberg, J M Griffiss
1Rehabilitation Medicine Service, San Francisco Veterans Administration Medical Center (SFVAMC) 94121.
Journal of Clinical Gastroenterology
|September 1, 1993
Summary
Medical ozone therapy via rectal insufflation shows promise for treating intractable diarrhea in patients with acquired immune deficiency syndrome (AIDS) or AIDS-related complex (ARC). This safe and simple treatment led to significant symptom resolution in most participants.
Area of Science:
- Immunology
- Gastroenterology
- Ozone Therapy
Background:
- Intractable diarrhea is a common and debilitating complication in patients with acquired immune deficiency syndrome (AIDS) or AIDS-related complex (ARC).
- Conventional treatments may be ineffective for some patients, necessitating exploration of alternative therapeutic options.
Purpose of the Study:
- To evaluate the safety and efficacy of medical ozone therapy administered by colonic insufflation for intractable diarrhea in patients with ARC/AIDS.
Main Methods:
- Five patients with ARC/AIDS and intractable diarrhea received daily colonic insufflations of an oxygen/ozone mixture for 21-28 days.
- Ozone doses ranged from 2.7 to 30 mg daily.
- Clinical outcomes, lymphocyte counts (CD4, CD8), blood gases, and routine blood work were monitored.
Main Results:
- Three of four patients with diarrhea of unknown etiology experienced complete resolution; one had marked improvement.
- The patient with Cryptosporidium-induced diarrhea showed no change.
- No significant adverse systemic effects were observed, though mild local discomfort occurred initially.
- No consistent changes in CD4/CD8 counts or routine blood parameters were detected.
Conclusions:
- Medical ozone administered by rectal insufflation appears to be a simple, safe, and potentially effective treatment for intractable diarrhea in certain ARC/AIDS patients.
- Further investigation is warranted to determine its routine clinical utility for chronic ARC/AIDS-related diarrhea.